Arcturus Therapeutics

Wall Street IPO initial public offering markets shares stock
Biotech

Arcturus' stock halves on cystic fibrosis readout

The findings have sent the biopharma’s stock crashing, falling 55% from $23.16 per share to $10.44 per share.
Gabrielle Masson Oct 22, 2025 1:01pm
Messenger RNA

Arcturus doubles down on mRNA, axes several early-stage assets

May 13, 2025 1:32pm
An artists depiction of an orange chicken pulling what is presumably a large influenza virus particle

'Highly unlikely' BARDA will pull bird flu vax funding: Arcturus

Mar 7, 2025 10:24am
next step ladder climb succeed win

Arcturus sa-mRNA COVID boosters induce immune response in ph. 2

Sep 19, 2023 11:40am
vaccines

Valneva, Arcturus add to chorus of COVID-19 vax booster data

Dec 16, 2021 10:10am
mRNA vaccine

The mRNA era after COVID-19: What's next in the pipeline

Sep 1, 2021 11:28am